NovoCure names Dr. Uri Weinberg CMO, adds CHF 5k/month stipend

NovoCure Ltd

Dr. Uri Weinberg, previously Chief Innovation Officer, also appointed Chief Medical Officer effective April 7, 2026.
Monthly salary increased by CHF 5,000 (gross) for the duration of the CMO assignment.
Stipend not included in annual incentive payment (AIP); all other terms unchanged.

item 5.02 item 9.01

NovoCure Ltd filing history →

Source: SEC EDGAR

accession 0001645113-26-000026

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.